Navigation Links
International Development Expert to Lead the Pan American Health and Education Foundation
Date:12/31/2007

WASHINGTON, Dec. 31 /PRNewswire-USNewswire/ -- The board of trustees of the Pan American Health and Education Foundation welcome Mr. Edward Kadunc as the new executive director. He comes to the foundation with 30 years of experience in international development, largely in Latin America. He follows Ms. Jess Gersky who is retiring at the end of this year.

Most recently, Mr. Kadunc served as the mission director in Mexico for the US Agency for International Development. He designed and implemented an HIV/AIDS Stigma Reduction in the Work Place program with leading US companies in Mexico and the Mexican Federal Secretary of Health. Among other projects, Mr. Kadunc also implemented a university partnership program involving over 100 Mexican and US universities.

Also he headed up USAID missions in Brazil, Colombia, the Dominican Republic, and Bosnia Herzegovina. Other countries where Mr. Kadunc served with distinction include Bolivia, Jamaica, Nicaragua, and Peru. Important areas in which he has demonstrated experience and leadership are public health and population, small business development, the environment, and economic reform.

PAHEF board chair, Dr. Malden Nesheim, says, "Mr. Kadunc has been recognized for his leadership through various awards, such as the Presidential Meritorious Honor Award. This coveted award honors high-performing professionals who are strong, effective leaders that embody integrity, hard work, and a commitment to excellence. We are excited to have him on board." Mr. Kadunc responds, "I am happy to accept this opportunity to lead the foundation. I am looking forward to implementing the mandate for continuity and strengthening of directions already taken."

The Pan American Health and Education Foundation is a US public charity working with the Pan American Health Organization to combat disease, lengthen life, improve health care services, foster health research, and enhance the capacities of health care
'/>"/>

SOURCE Pan American Health and Education Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...alth-related Questions for Tonight,s,Presidential ...- WebMD, the leading source of,health information,...ial,candidates, proposed health care policies, loc...t the candidates, stance on health insurance, medi... public health issues., The in-depth coverage is ...
(Date:10/7/2008)...PRNewswire-USNewswire/ -- The Ohio Nurses,Associat...ced today its,final round of endorsed candidates f...o Senate:, SD 26 Karen Gillmor (R) Tiffin, Ohio ...(R) Grove City;, HD 28 Connie Pillich (D) Cincinn...These ONA-endorsed candidates for the Ohio General...
(Date:10/7/2008)...wswire-USNewswire/ -- Kristi Yamaguchi, Olympic,Go... the Stars, has been,named chairperson for the 200...gn in an effort to help raise funds in support of ...e and promote lung health., The American Lung Ass...o conquer Tuberculosis. Today, the Lung Associatio...
(Date:10/7/2008)...ar to more expensive whole-leg color ultrasound, ...lthDay News) -- An older, simpler test to look for...osis, or DVT -- is as effective as a newer, more e...searchers found that 2-point ultrasonography of th...trasound -- was as good at detecting DVT as the ne...
Breaking Medicine News(10 mins):Health News:WebMD Highlights Presidential Candidates' Views on Health Care 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 2Health News:ONA-PCE Announces Final Round of Endorsed Candidates for Ohio General Assembly 3Health News:Kristi Yamaguchi Chairs American Lung Association Christmas Seals Campaign 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 2Health News:Simpler Test May Be Best for Diagnosing Blood Clots in Leg 3
...Susan Butcher the famous iditarod champion was det...rticipate in the 300-mile sled dog race conducted ...of the 1100-mile Iditarod Trail Sled Dog Race. She...ce of survival with the same grit and confidence. ...
...There appears to be a remarkable laxity among the ...ng skin cancer. Felipe Beltran, the spokesman for ... has admitted that the organization’s drive agains...ed impact. The online study of the QIMR did not e...
...Researchers from Germany have discovered a novel, ...of coronary veins. This technique, called ECG-gate...DCT, is associated with very few complications // ... improved diagnostic quality and treatment. A com...
...A research was conducted by Selda Samakoglu and co...nter. This research opened new doors in the treatm.... The treatment combines both gene therapy and RNA...eatment has worked well in the laboratory stage an...
Other Medicine News:Health News:Treatment of Sickle Cell Anemia Using Gene Therapy. 2
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific...stCall/ -- Ironwood,Pharmaceuticals, Inc. (formerl...YSE: FRX ) today announced the presentation of re...s safety and efficacy in 420 patients with,irritab...sis of the data,indicates that once- daily oral do...
(Date:10/7/2008)...RKELEY, Calif., Oct. 7 /- Aerovance I... data from a Phase I trial of its Aerovant,inhalat... no evidence of,local irritancy following asthma p... 10 mg dose will be the highest of three doses inv...udy, which is scheduled to begin early,next year. ...
(Date:10/7/2008)...tient, Prospective Randomized Placebo-Controlled P...cant Improved Overall Survival., MOUNTAIN VIEW, C...apeutics has now evaluated the mature Phase II dat...didate PROSTVAC(TM) that had been,obtained as part...onal,Cancer Institute (NCI) in the US., The resul...
(Date:10/7/2008)...nned 15 Patient Cohort Enrolled in Stage A of Tria...on With Carboplatin and Paclitaxel -, TUSTIN, Cal...armaceuticals, Inc. (Nasdaq: PPHM ), a clinical s...al antibodies for the treatment of cancer and,hepa...t it has completed,enrollment in the first stage o...
Breaking Medicine Technology:Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4CorVel Announces Appearance at Bank of America Health Care Conference 18732 1CorVel Announces Appearance at Bank of America Health Care Conference 18732 2San Diego State University Controlled Substance Investigation 18730 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 1Workers With No Healthcare Protecting Kaiser Facilities Security Contractor May Be Misleading Californias Largest Healthcare Provider 18728 2Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 1Physical Therapist Stresses Funding for Falls Prevention at National Safety Council Briefing 18726 2
... Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Gloucester...rmaceutical,company, announced today that encourag...mbination of romidepsin and erlotinib in,non-small...human,cancer patients were presented at the Americ...eeting taking place in Los Angles,CA. The study w...
...ies Confirm That Fusion Proteins Made by Combining...onstrate Increased,Anti-Tumor Activity With No Obs..., April 18, 2007,/PRNewswire-FirstCall/ -- Peregri...rmaceutical company developing targeted,monoclonal...tis C,virus infection, today reported that data pr...
Other Medicine Technology:Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 2Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4
...ing: The Procleix System has added a significant ... utilizes innovative technologies developed by Gen...eic acid amplification technique called Transcript...V-1/HCV Assay can simultaneously detect the presen...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca
...assay: Uni-Gold Recombigen HIV is a single use rap...in plasma, serum and whole blood (venipuncture). U...t of care settings as an aid in diagnosis of infec...appropriate multi-test algorithms designed for the...
The advanced performance benefits of TiMAX material have been applied to the ACE Pe.R.I. (Periarticular Reduction Implants) Upper Extremity Plates. Greater strength, less rigidity combine to provide
Medicine Products: